Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 95.03 is 726% above its estimated 5-year average of 11.50, near the low end of its estimated 5-year range (2.06–457.69).
As of 2026-10-06T18:56:43.962Z. 31.02% above its estimated 12-month average of 72.53.
Calculation as of: 2026-10-06T18:56:43.962Z.
Quote observation: 2026-10-06T18:55:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b4a4fa98aa52f375fdc5874331a43a09dc7975e501838f67450551c218d6975f
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
95.03
PS RATIO AVG TTM
72.53
PS RATIO AVG 3Y
15.86
PS RATIO AVG 5Y
11.50
PS RATIO AVG 10Y
14.15
PS RATIO AVG 15Y
19.76
PS RATIO AVG 20Y
19.45
CURRENT VS TTM AVG
+31.02%
CURRENT VS 3Y AVG
+499.07%
CURRENT VS 5Y AVG
+726.24%
CURRENT VS 10Y AVG
+571.40%
CURRENT VS 15Y AVG
+380.95%
CURRENT VS 20Y AVG
+388.49%
SECTOR MEDIAN · HEALTHCARE
4.30
median of 579 covered companies
CURRENT VS SECTOR MEDIAN
+2110.00%
vs the sector median at left
EyePoint Pharmaceuticals, Inc.
Market Cap
$265.04M
PS Ratio
95.03
TTM Avg
72.53
3Y Avg
15.86
5Y Avg
11.50
Market Cap
$264.73M
PS Ratio
N/A
TTM Avg
8336935.98
3Y Avg
3234328.97
5Y Avg
2173022.38
Market Cap
$267.28M
PS Ratio
1.30
TTM Avg
1.03
3Y Avg
2.12
5Y Avg
5.30
Market Cap
$262.39M
PS Ratio
N/A
TTM Avg
557.62
3Y Avg
557.62
5Y Avg
557.62
Market Cap
$261.74M
PS Ratio
16.52
TTM Avg
22.58
3Y Avg
53.44
5Y Avg
53.44
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | $265.04M | 95.03 | 72.53 | 15.86 | 11.50 |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.73M | N/A | 8336935.98 | 3234328.97 | 2173022.38 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $263.82M | N/A | N/A | N/A | N/A |
| Treace Medical Concepts, Inc. (TMCI)vs › | $267.28M | 1.30 | 1.03 | 2.12 | 5.30 |
| Palisade Bio, Inc. (PALI)vs › | $261.25M | 522.51 | 794.15 | 209.97 | 146.32 |
| OraSure Technologies, Inc. (OSUR)vs › | $261.97M | 2.33 | 1.95 | 1.47 | 1.49 |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $262.39M | N/A | 557.62 | 557.62 | 557.62 |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.74M | 16.52 | 22.58 | 53.44 | 53.44 |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $270.34M | 1.25 | 1.73 | 1.50 | 1.77 |
| SAB Biotherapeutics, Inc. (SABS)vs › | $270.68M | N/A | 884.25 | 301.04 | 211.12 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $966,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $620,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-05 |
| Q1 FY2026Period ended 2026-03-31 | $696,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $507,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $2,789,000 |
Current P/S: $265,039,115 market capitalization ÷ $2,789,000 TTM revenue = 95.03x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:55:17.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 95.03, P/S is above its estimated 20-year median — higher than 98% of readings in its estimated 20-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 20-year low
1.23
median
10.52
estimated 20-year high
457.69
P/S Ratio
95.03
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 97.74 |
| 2026-10-02 | 100.85 |
| 2026-10-01 | 100.23 |
| 2026-09-30 | 101.47 |
| 2026-09-29 | 106.12 |
| 2026-09-28 | 102.71 |
| 2026-09-25 | 112.33 |
| 2026-09-24 | 113.26 |
| 2026-09-23 | 115.43 |
| 2026-09-22 | 126.29 |
| 2026-09-21 | 124.74 |
| 2026-09-18 | 119.47 |
| 2026-09-17 | 123.81 |
| 2026-09-16 | 107.05 |
| 2026-09-15 | 113.57 |
| 2026-09-14 | 131.88 |
| 2026-09-11 | 131.26 |
| 2026-09-10 | 131.88 |
| 2026-09-09 | 134.67 |
| 2026-09-08 | 141.50 |
| 2026-09-04 | 142.12 |
| 2026-09-03 | 141.81 |
| 2026-09-02 | 148.63 |
| 2026-09-01 | 142.12 |
| 2026-08-31 | 139.64 |
| 2026-08-28 | 139.01 |
| 2026-08-27 | 143.67 |
| 2026-08-26 | 154.84 |
| 2026-08-25 | 155.46 |
| 2026-08-24 | 151.12 |
| 2026-08-21 | 165.08 |
| 2026-08-20 | 167.56 |
| 2026-08-19 | 195.49 |
| 2026-08-18 | 169.73 |
| 2026-08-17 | 151.12 |
| 2026-08-14 | 457.69 |
| 2026-08-13 | 418.29 |
| 2026-08-12 | 419.84 |
| 2026-08-11 | 404.94 |
| 2026-08-10 | 405.56 |
| 2026-08-07 | 431.01 |
| 2026-08-06 | 398.12 |
| 2026-08-05 | 138.34 |
| 2026-08-04 | 131.79 |
| 2026-08-03 | 140.26 |
| 2026-07-31 | 138.34 |
| 2026-07-30 | 145.23 |
| 2026-07-29 | 134.62 |
| 2026-07-28 | 135.07 |
| 2026-07-27 | 140.15 |
| 2026-07-24 | 137.67 |
| 2026-07-23 | 140.83 |
| 2026-07-22 | 142.97 |
| 2026-07-21 | 147.38 |
| 2026-07-20 | 142.97 |
| 2026-07-17 | 150.20 |
| 2026-07-16 | 147.27 |
| 2026-07-15 | 156.41 |
| 2026-07-14 | 155.06 |
| 2026-07-13 | 161.27 |
| 2026-07-10 | 166.24 |
| 2026-07-09 | 167.59 |
| 2026-07-08 | 158.22 |
| 2026-07-07 | 158.33 |
| 2026-07-06 | 163.08 |
| 2026-07-02 | 157.88 |
| 2026-07-01 | 149.07 |
| 2026-06-30 | 161.50 |
| 2026-06-29 | 159.35 |
| 2026-06-26 | 154.27 |
| 2026-06-25 | 154.83 |
| 2026-06-24 | 162.62 |
| 2026-06-23 | 162.40 |
| 2026-06-22 | 155.06 |
| 2026-06-18 | 153.36 |
| 2026-06-17 | 148.51 |
| 2026-06-16 | 145.46 |
| 2026-06-15 | 136.42 |
| 2026-06-12 | 147.15 |
| 2026-06-11 | 141.17 |
| 2026-06-10 | 139.25 |
| 2026-06-09 | 132.92 |
| 2026-06-08 | 129.31 |
| 2026-06-05 | 133.04 |
| 2026-06-04 | 138.46 |
| 2026-06-03 | 139.36 |
| 2026-06-02 | 141.51 |
| 2026-06-01 | 148.51 |
| 2026-05-29 | 153.36 |
| 2026-05-28 | 152.46 |
| 2026-05-27 | 148.62 |
| 2026-05-26 | 150.77 |
| 2026-05-22 | 146.02 |
| 2026-05-21 | 144.33 |
| 2026-05-20 | 141.17 |
| 2026-05-19 | 133.49 |
| 2026-05-18 | 132.13 |
| 2026-05-15 | 139.47 |
| 2026-05-14 | 149.52 |
| 2026-05-13 | 151.67 |
| 2026-05-12 | 153.82 |
| 2026-05-11 | 157.88 |
| 2026-05-08 | 154.27 |
| 2026-05-07 | 35.49 |
| 2026-05-06 | 35.33 |
| 2026-05-05 | 36.39 |
| 2026-05-04 | 36.66 |
| 2026-05-01 | 35.31 |
| 2026-04-30 | 34.94 |
| 2026-04-29 | 34.04 |
| 2026-04-28 | 35.65 |
| 2026-04-27 | 35.99 |
| 2026-04-24 | 36.44 |
| 2026-04-23 | 36.63 |
| 2026-04-22 | 37.69 |
| 2026-04-21 | 37.34 |
| 2026-04-20 | 39.89 |
| 2026-04-17 | 39.51 |
| 2026-04-16 | 39.20 |
| 2026-04-15 | 38.72 |
| 2026-04-14 | 37.95 |
| 2026-04-13 | 38.43 |
| 2026-04-10 | 37.56 |
| 2026-04-09 | 37.66 |
| 2026-04-08 | 37.50 |
| 2026-04-07 | 35.92 |
| 2026-04-06 | 34.70 |
| 2026-04-02 | 35.47 |
| 2026-04-01 | 34.46 |
| 2026-03-31 | 34.12 |
| 2026-03-30 | 31.36 |
| 2026-03-27 | 33.08 |
| 2026-03-26 | 34.57 |
| 2026-03-25 | 34.54 |
| 2026-03-24 | 33.32 |
| 2026-03-23 | 33.96 |
| 2026-03-20 | 35.02 |
| 2026-03-19 | 36.50 |
| 2026-03-18 | 36.10 |
| 2026-03-17 | 36.79 |
| 2026-03-16 | 35.60 |
| 2026-03-13 | 34.94 |
| 2026-03-12 | 37.13 |
| 2026-03-11 | 39.49 |
| 2026-03-10 | 40.86 |
| 2026-03-09 | 41.47 |
| 2026-03-06 | 41.68 |
| 2026-03-05 | 26.12 |
| 2026-03-04 | 29.83 |
| 2026-03-03 | 30.36 |
| 2026-03-02 | 30.39 |
| 2026-02-27 | 29.10 |
| 2026-02-26 | 29.60 |
| 2026-02-25 | 29.43 |
| 2026-02-24 | 28.26 |
| 2026-02-23 | 28.29 |
| 2026-02-20 | 25.41 |
| 2026-02-19 | 24.36 |
| 2026-02-18 | 23.80 |
| 2026-02-17 | 24.71 |
| 2026-02-13 | 21.44 |
| 2026-02-12 | 21.56 |
| 2026-02-11 | 21.30 |
| 2026-02-10 | 22.74 |
| 2026-02-09 | 23.32 |
| 2026-02-06 | 22.04 |
| 2026-02-05 | 21.10 |
| 2026-02-04 | 20.43 |
| 2026-02-03 | 21.21 |
| 2026-02-02 | 22.02 |
| 2026-01-30 | 22.41 |
| 2026-01-29 | 24.44 |
| 2026-01-28 | 24.93 |
| 2026-01-27 | 26.20 |
| 2026-01-26 | 25.60 |
| 2026-01-23 | 25.16 |
| 2026-01-22 | 27.08 |
| 2026-01-21 | 25.74 |
| 2026-01-20 | 25.75 |
| 2026-01-16 | 24.99 |
| 2026-01-15 | 26.25 |
| 2026-01-14 | 26.38 |
| 2026-01-13 | 26.40 |
| 2026-01-12 | 26.42 |
| 2026-01-09 | 26.90 |
| 2026-01-08 | 28.31 |
| 2026-01-07 | 28.79 |
| 2026-01-06 | 27.94 |
| 2026-01-05 | 28.89 |
| 2026-01-02 | 28.97 |
| 2025-12-31 | 30.28 |
| 2025-12-30 | 29.65 |
| 2025-12-29 | 30.16 |
| 2025-12-26 | 30.31 |
| 2025-12-24 | 30.26 |
| 2025-12-23 | 30.46 |
| 2025-12-22 | 31.24 |
| 2025-12-19 | 28.89 |
| 2025-12-18 | 28.27 |
| 2025-12-17 | 27.61 |
| 2025-12-16 | 28.06 |
| 2025-12-15 | 27.18 |
| 2025-12-12 | 26.50 |
| 2025-12-11 | 26.68 |
| 2025-12-10 | 27.71 |
| 2025-12-09 | 28.31 |
| 2025-12-08 | 29.53 |
| 2025-12-05 | 29.40 |
| 2025-12-04 | 27.71 |
| 2025-12-03 | 24.06 |
| 2025-12-02 | 22.69 |
| 2025-12-01 | 23.63 |
| 2025-11-28 | 24.58 |
| 2025-11-26 | 24.51 |
| 2025-11-25 | 24.43 |
| 2025-11-24 | 23.86 |
| 2025-11-21 | 22.67 |
| 2025-11-20 | 22.60 |
| 2025-11-19 | 23.67 |
| 2025-11-18 | 23.14 |
| 2025-11-17 | 21.78 |
| 2025-11-14 | 19.19 |
| 2025-11-13 | 19.07 |
| 2025-11-12 | 19.87 |
| 2025-11-11 | 19.31 |
| 2025-11-10 | 18.81 |
| 2025-11-07 | 18.58 |
| 2025-11-06 | 14.93 |
| 2025-11-05 | 14.85 |
| 2025-11-04 | 16.69 |
| 2025-11-03 | 16.77 |
| 2025-10-31 | 17.64 |
| 2025-10-30 | 16.45 |
| 2025-10-29 | 15.80 |
| 2025-10-28 | 16.51 |
| 2025-10-27 | 16.32 |
| 2025-10-24 | 16.14 |
| 2025-10-23 | 15.49 |
| 2025-10-22 | 15.43 |
| 2025-10-21 | 15.91 |
| 2025-10-20 | 16.21 |
| 2025-10-17 | 15.67 |
| 2025-10-16 | 15.56 |
| 2025-10-15 | 15.80 |
| 2025-10-14 | 17.73 |
| 2025-10-13 | 17.97 |
| 2025-10-10 | 18.28 |
| 2025-10-09 | 18.84 |
| 2025-10-08 | 18.70 |
| 2025-10-07 | 17.85 |
| 2025-10-06 | 18.35 |
| 2025-10-03 | 18.50 |
| 2025-10-02 | 18.19 |
| 2025-10-01 | 17.41 |
| 2025-09-30 | 19.19 |
| 2025-09-29 | 18.93 |
| 2025-09-26 | 18.73 |
| 2025-09-25 | 17.77 |
| 2025-09-24 | 18.97 |
| 2025-09-23 | 18.04 |
Showing the most recent 260 of 4,848 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.